Strategic Plan

Discovery Lecture explores health care cost controls

“There’s no magic bullet” to control rising health care costs in the United States, health law expert Timothy Jost, J.D., said during last week’s Flexner Discovery Lecture.

Study shows lower systolic BP targets reduce death risk

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.

Craig Hutto and Michael Goldfarb

Surgery and engineering initiative becomes institute

VISE is keeping its acronym but changing its name. The Vanderbilt Initiative in Surgery and Engineering will become the Vanderbilt Institute in Surgery and Engineering.

genetic sequence

Grants spur effort to add genetic data to EMR

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

Insulin in vials

Diabetes trial targets body’s ability to produce insulin

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

microscope

Initiative seeks to bolster ‘rediscovery research’

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.

1 9 10 11 12 13 16